Cannabis Bioscience International Inc. (CBIH)
OTC
Closed
Oct 19, 2026
Day's Range
0.00010052 wk Range
0.000100Overview - CBIH - Cannabis Bioscience International Inc.
Key Statistics
Valuation
Enterprise Value
3.54M
P/E (Trailing)
‪0.07‬
PEG Ratio
‪0.0060‬
Price / Sales (TTM)
‪18.80‬
Price / Book
‪-0.79‬
EV / EBITDA
‪-9.12‬
Profitability
Gross Margin
‪72.82%‬
Profit Margin
‪86.76%‬
Operating Margin
‪-832.29%‬
Return on Assets
‪-3,034.24%‬
Return on Equity
‪47.16%‬
Ownership
Shares Outstanding
11.62B
Float
5.08B
Held by Insiders
‪58.41%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.94‬
50-Day Avg
‪0.00016‬
200-Day Avg
‪0.00033‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CBIH - Cannabis Bioscience International Inc.
Peers - CBIH - Cannabis Bioscience International Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
- CBIHOTCCannabis Bioscience International Inc.1.16MMarket Cap-300.00%52-week change0.07P/E (Trailing)‪86.76%‬Profit Margin
- MKGAFOTCMerck KGaA70.34BMarket Cap+16.01%52-week change25.44P/E (Trailing)‪11.21%‬Profit Margin
- MKKGYOTCMerck KGaA Sponsored ADR70.23BMarket Cap+18.25%52-week change25.41P/E (Trailing)‪11.21%‬Profit Margin
- GDERFOTCGalderma Group AG50.53BMarket Cap+24.28%52-week change60.42P/E (Trailing)‪14.57%‬Profit Margin
- GALDYOTCGalderma Group AG Unsponsored ADR49.43BMarket Cap+16.89%52-week change58.08P/E (Trailing)‪14.57%‬Profit Margin
- HLNCFOTCHaleon plc40.76BMarket Cap+5.07%52-week change19.31P/E (Trailing)‪14.55%‬Profit Margin
- JHPCYOTCJiangsu Hengrui Pharmaceuticals Co. Ltd.40.65BMarket Cap-38.44%52-week change37.12P/E (Trailing)‪86.20%‬Profit Margin
Profile Summary - CBIH - Cannabis Bioscience International Inc.
About
Cannabis Bioscience International Inc. is a research-driven organization operating within the biotechnology and pharmaceuticals industry. Its primary focus is on the development and commercialization of medical-grade cannabis products. Utilizing cutting-edge bioscience technology, the company aims to enhance the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
